Archive ready

一般財団法人化学及血清療法研究所が製造販売する組換え沈降B型肝炎ワクチン(酵母由来)、乾燥組織培養不活化A型肝炎ワクチンについて|厚生労働省

https://www.mhlw.go.jp/stf/houdou/0000110599.html
April 4, 2026 at 09:30 AM JSTThe archive page, viewer, and downloads use this saved version.
April 4, 2026 at 09:30 AM JST·www.mhlw.go.jp

一般財団法人化学及血清療法研究所が製造販売する組換え沈降B型肝炎ワクチン(酵母由来)、乾燥組織培養不活化A型肝炎ワクチンについて|厚生労働省

Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.

StartedApril 4, 2026 at 09:30 AM JST

This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.

The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.

About this pageAI generated

This page announces the Ministry of Health, Labour and Welfare's decision to lift the shipment suspension of hepatitis B vaccine "Beamgen" and hepatitis A vaccine "Eimgen" manufactured by the Chemical and Serum Therapy Research Institute. The suspension was issued in September 2015 due to discrepancies between approved specifications and actual manufacturing practices. After detailed review, authorities determined no significant impact on quality and safety. Based on the Infectious Disease Subcommittee's recommendation and supply shortage concerns, shipment approval was restored.

一般財団法人化学及血清療法研究所が製造販売する組換え沈降B型肝炎ワクチン(酵母由来)、乾燥組織培養不活化A型肝炎ワクチンについて|厚生労働省 - Saved screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.